TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
UPB

Upstream Bio, Inc.

Healthcare · Biotechnology · —

5.20$ -5.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

Upstream Bio, Inc. (UPB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -36 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow UPB
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
-4.8 -16 -18 -8.0 -14 -20 -41 -39 -22 -31 -48 -36 -136
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 -2.8 5.9 -0.7 0.1 2.4
0.7 0.8 0.6 1.4 1.9 2.1 2.6 2.6 2.6 2.5 4.6 4.4 14
3.1 -4.0 -3.9 6.3 0.7 -1.3 -15 -1.1 8.9 7.7 -11 -0.4 4.8
0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1
12 -5.2 14 -117 1.4 42 -213 13 48 59 42 16 165
0.1 -0.1 9.4 141 -1.6 271 0.0 0.6 0.8 1.1 0.6 2.5 5.0
7.5 -21 5.7 16 -14 293 -255 -26 27 29 -4.9 -17 34
-4.8 -16 -18 -8.0 -14 -20 -41 -39 -22 -31 -48 -36 -136

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?